Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-060535)

Filing Details

Accession Number:: 0001209191-19-060535
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-16 06:21:27
Reporting Period:: 2019-12-13

Accepted Time:: 2019-12-16 06:21:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1478069	Contrafect Corp	CFRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615047	N. David Low	4 Embarcadero Center Suite 650 San Francisco CA 94111		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2019-12-13	300,000	$0.43	370,550	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase reported in this Form 4 was made on the open market.
The price reported is a weighted average price based on the shares purchased in multiple transactions. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price comprising the average set forth herein.